Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 28.
doi: 10.1007/s12602-024-10297-1. Online ahead of print.

The Therapeutic Effects of Probiotic on Systemic Lupus Erythematosus in Lupus Mice Models: A Systematic Review

Rachael Chaeh-Wen Goh  1 , Mari Kannan Maharajan  2 , Divya Gopinath  3   4 , Chee-Mun Fang  5
Affiliations
Review

The Therapeutic Effects of Probiotic on Systemic Lupus Erythematosus in Lupus Mice Models: A Systematic Review

Rachael Chaeh-Wen Goh et al. Probiotics Antimicrob Proteins. .

Abstract

Increasing evidence suggests the beneficial immunomodulatory effects of probiotics can reduce inflammation in systemic lupus erythematosus (SLE). However, there is no summary of the existing evidence available. This study aims to investigate the therapeutic effects of probiotics on SLE in a lupus mouse model by examining various markers, including inflammatory cytokines, Treg cells, disease activity, and gut microbiota. A systematic search was conducted using three databases (Web of Science, PubMed, and Scopus) to identify animal studies that reported the therapeutic benefits of probiotics against SLE. Data extracted from the selected articles were qualitatively synthesized. The SYRCLE risk of bias tool was used to evaluate the risk of bias. Out of a total of 3205 articles, 12 met the inclusion criteria. Probiotic strains, quantities, and routes of administration varied among the studies. The treatment ranged from 8 to 47 weeks. Probiotic strains such as L. fermentum CECT5716, L. casei B255, L. reuteri DSM 17509, L. plantarum LP299v, and L. acidophilus can significantly reduce pro-inflammatory cytokines (TNF-α, IL-12, IL-6, IL-1β, IL-17, and IFN-γ) levels while increasing anti-inflammatory IL-10 and Treg cells. Probiotics also delay the production of autoantibodies, thus prolonging the remission period, decreasing flare frequency, and delaying disease progression. Furthermore, probiotic administration prevents gut dysbiosis, increases intestinal stability, and prevents pathogen colonization. In conclusion, probiotics can be considered a new alternative therapeutic approach for the management of SLE. Further clinical studies are required to investigate and validate the safety and effectiveness of probiotics in humans.

Keywords: Anti-inflammatory cytokines; Lupus mice models; Pro-inflammatory cytokines; Probiotics; Systemic lupus erythematosus.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Karrar S, Cunninghame Graham DS (2018) Abnormal B cell development in systemic lupus erythematosus: what the genetics tell us. Arthritis Rheumatol 70:496. https://doi.org/10.1002/ART.40396 - DOI - PubMed - PMC
    1. Tian J, Zhang D, Yao X et al (2023) Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study. Ann Rheum Dis 82:351–356. https://doi.org/10.1136/ARD-2022-223035 - DOI - PubMed
    1. Barber MRW, Drenkard C, Falasinnu T et al (2021) Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol 17:515. https://doi.org/10.1038/S41584-021-00668-1 - DOI - PubMed - PMC
    1. Allen ME, Rus V, Szeto GL (2021) Leveraging heterogeneity in systemic lupus erythematosus for new therapies. Trends Mol Med 27:152. https://doi.org/10.1016/J.MOLMED.2020.09.009 - DOI - PubMed
    1. Pan L, Lu MP, Wang JH et al (2020) Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatrics 16:19–30. https://doi.org/10.1007/S12519-019-00229-3/FIGURES/4 - DOI

LinkOut - more resources